NEXON does not pass the ethical screen. The binding factor is interest/revenue 7.8%.
NEXON Co., Ltd.
NEXOY · PNK · USD · Market cap $13.6B
FAIL · Does not pass the screenPrice as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 06:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price17.64 USD at the 23 Oct 2026 close
- Our ratingAvoid, current read distribution
- Ethical screenDoes not pass
- Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 17.64 against the desk's fair-value range, over the last year.
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
NEXON Co., Ltd. holds its Distribution at $17.64. Consolidating, no directional conviction, held for 18 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 18 days |
| Price at the screen | $17.64 |
| Valuation | 15.68 trailing · N/A forward price to earnings |
| Values screen | FAIL |
| Beta | 0.57 |
Five Screens, Shown in Full
Does not pass. Interest/revenue 7.8%
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 0.00% | Below 33% | Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 7.84% | Below 5% | 7.8% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
NEXON does not pass the ethical screen. The binding factor is interest/revenue 7.8%.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
NEXON clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
Follow this verdict
Get an email when NEXOY's ethical verdict changes
Today NEXOY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads AVOID: 1.90% revenue growth.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
On our numbers, the price already runs ahead of the business.
| Trailing P/E | 15.7xreasonably valued |
| EPS, trailing | 1.11 |
| Revenue growth | +1.9%slow but positive growth |
| Profit margin | 26.4%healthy profit margins |
| Return on equity | 12.5%a solid return on shareholder capital |
| FCF yield | 811.42% |
| Dividend yield | 190.00% |
| Debt to equity | 4.55heavy leverage: higher risk if revenue softens |
| Current ratio | 5.85comfortably covers its short-term bills |
| Beta | 0.57steadier than the market |
| 52-week range | 13.01 - 28.82 |
| Market cap | $13.6B |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeNEXOY trades on PNK. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 13.9% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. Since the last review it dropped out of the Tech 100.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 20.3% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 17.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- NEXON Co Ltd's Dividend Analysis Yahoo Finance · 30d ago
- NEXON Co Ltd (NEXOF) (Q2 2026) Earnings Call Highlights: Record MapleStory Performance and ... GuruFocus.com · 17 Aug 2026
- NEXON Co Ltd (NEXOF) (Q2 2026) Earnings Call Highlights: Record MapleStory Performance and ... Yahoo Finance · 17 Aug 2026
- Earnings Results, Soft US Inflation Report Lift Asian Stock Markets MT Newswires · 14 Aug 2026
- Earnings Results, Soft US Inflation Report Lift Asian Stock Markets Yahoo Finance · 14 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $17.10 | -20.8% | · | $792 | -20.8% |
| 2 months | $16.75 | -19.2% | · | $808 | -19.2% |
| 3 months | $19.00 | -28.7% | · | $713 | -28.7% |
| 6 months | $24.82 | -45.5% | · | $546 | -45.5% |
| 1 year | $18.04 | -24.9% | · | $751 | -24.9% |
| 2 years | $17.52 | -22.7% | $0.10 | $778 | -22.2% |
| 3 years | $20.34 | -33.4% | $0.10 | $671 | -32.9% |
| 5 years | $22.78 | -40.6% | $0.10 | $599 | -40.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever NEXOY does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.